跳至主要内容
临床试验/PACTR202010511829332
PACTR202010511829332已完成4 期

In vivo and in vitro anti-hookworm effect of Single dose of Albendazole among outpatients at Adet primary Hospital, Northwest, Ethiopia

未提供0 个研究点目标入组 50 人开始时间: 2020年10月12日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Year(s) 至 5 Year(s)(—)
性别
All

入选标准

  • ? All outpatients agree to comply with study procedures, including the provision of two enough stool samples at the beginning (baseline) and at post-treatment follow up assessments (approximately 2 weeks, later).
  • ? All hookworm positive study participants > 2 years old
  • ? Both sex (female and male ) hookworm positive participants

排除标准

  • ? Pregnant women
  • ? Patients undertake anthelminthic drugs during data collection time within the past 6 weeks)
  • ? Participants with medication with known interaction (e.g. for albendazole: cimetidine, praziquantel, and dexamethasone)
  • ? Patients who had a history of severe chronic disease (e.g.cancer, diabetes, chronic heart, liver or renal disease).
  • ? Participants having diarrhea or vomiting

研究者

发起方
未提供

相似试验